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AbstrACt
Introduction Research into what constitutes the best 
and most effective care for women with an acute severe 
postpartum mental disorder is lacking. The effectiveness 
and cost-effectiveness of psychiatric mother and baby 
units (MBUs) has not been investigated systematically and 
there has been no direct comparison of the outcomes of 
mothers and infants admitted to these units, compared 
with those accessing generic acute psychiatric wards or 
crisis resolution teams (CRTs). Our primary hypothesis is 
that women with an acute psychiatric disorder, in the first 
year after giving birth, admitted to MBUs are significantly 
less likely to be readmitted to acute care (an MBU, CRTs or 
generic acute ward) in the year following discharge than 
women admitted to generic acute wards or cared for by 
CRTs.
Methods and analysis Quasi-experimental study of 
women accessing different types of acute psychiatric 
services in the first year after childbirth. Analysis of the 
primary outcome will be compared across the three 
service types, at 1-year postdischarge. Cost-effectiveness 
will be compared across the three service types, at 
1-month and 1-year postdischarge; explored in terms of 
quality-adjusted life years. Secondary outcomes include 
unmet needs, service satisfaction, maternal adjustment, 
quality of mother–infant interaction. Outcomes will 
be analysed using propensity scoring to account for 
systematic differences between MBU and non-MBU 
participants. Analyses will take place separately within 
strata, defined by the propensity score, and estimates 
pooled to produce an average treatment effect with 
weights to account for cohort attrition.
Ethics and dissemination The study has National Health 
Service (NHS) Ethics Approval and NHS Trust Research 
and Development approvals. The study has produced 
protocols on safeguarding maternal/child welfare. With 
input from our lived experience group, we have developed 
a dissemination strategy for academics/policy-makers/
public.
IntroduCtIon
Severe postpartum psychiatric disorders are 
among the most challenging to treat as they 
are rapid in onset, can deteriorate quickly and 
are a leading cause of maternal death from 
suicide.1 These disorders may also be associ-
ated with deficits in caring for the newborn 
strengths and limitations of this study
 ► Women with lived experience of acute postnatal 
mental disorders have advocated a study of this kind 
for a number of years, and a lived experience group 
informed the development of this study.
 ► This study will be the first study to provide evidence 
on the relative effectiveness and cost-effectiveness 
of mother and baby units, generic acute psychiatric 
wards and crisis resolution teams.
 ► A randomised controlled trial study design was not 
possible due to the large geographical inequity in 
service provision leading to logistical challenges for 
randomisation, ethical difficulties in asking women 
for consent to randomisation when acutely dis-
tressed and ill, and strong service preferences of 
staff, women and families.
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baby and disruptions in the mother–baby relationship.1–3 
Over the longer term, the children of mothers admitted 
to inpatient psychiatric services may develop a range of 
health, developmental and mental health concerns.4 
A recent examination of the costs of perinatal mental 
health problems indicates that the greatest costs relate to 
adverse child outcomes.5 
Severe postpartum episodes (which include puer-
peral psychosis, severe depression or a relapse of bipolar 
disorder)1 6 require acute care which, in most countries, 
usually means hospital admission,6 either in psychi-
atric mother and baby units (MBUs; available in some 
parts of Europe, Asia, North America and Australia) or 
generic inpatient wards. MBUs admit mothers and babies 
together so that mothers can spend time with their baby 
as their mental state improves and, potentially, receive 
help for any difficulties in the mother–infant relation-
ship.7 8 Such units are not, however, available everywhere 
internationally9 and data on effectiveness and cost-effec-
tiveness are lacking. In the UK, MBUs are not equally 
distributed geographically, although this is gradually 
changing with recent new funding.10 The UK National 
Institute for Health and Care Excellence (NICE) and the 
Royal College of Psychiatrists recommend that women 
who develop severe postpartum disorders should be 
cared for in specialist psychiatric MBUs but evidence to 
inform commissioning of services on effectiveness and 
cost-effectiveness is lacking.
Historically, including at the time of recruitment to 
this study, women in the UK with acute postnatal illnesses 
could be admitted to generic acute wards, either because 
access to an MBU was not possible because of geograph-
ical distance or a lack of available beds; such admissions 
necessitate separation from the baby. Alternatively, women 
could be cared for at home by intensive home treatment 
teams, also known as crisis resolution teams (CRTs). CRTs 
care for people who do not require detention under the 
Mental Health Act but who are experiencing an acute 
psychiatric episode that would otherwise require hospi-
talisation. Such teams became available in all National 
Health Service (NHS) Trusts in England by 2005 and, 
depending on need, staff can visit service users in their 
homes daily to avoid acute admission.11 12 CRTs treat the 
mother in her own home and the baby can often remain 
with her and with her partner or other sources of support.
Research into what constitutes the best and most effec-
tive care for women with an acute severe postpartum 
mental disorder is lacking. The effectiveness and cost-ef-
fectiveness of MBUs has not been investigated systemat-
ically.13 Several studies of MBU admissions describe the 
clinical and parenting outcomes of mothers14–20; two 
studies report improvements in mother–infant interac-
tions before and after participation in specific mother–
infant video feedback interventions,2 3 although such 
before and after designs did not randomise mothers or 
use a control group comparison. Given limited resources 
and significant costs of specialist care services, there 
remains a pressing need for high-quality evidence of 
the clinical and cost-effectiveness of MBU admission for 
mothers and infants compared with generic acute wards 
or CRT services.13
Comparison of clinical interventions should be 
undertaken using a randomised controlled trial design. 
However, in this population, it is not considered ethical 
or practical to randomise women, in part because of the 
large distances many women would need to travel for 
admission to an MBU leading to logistical challenges for 
randomisation, ethical difficulties in asking women for 
consent to randomisation when acutely distressed and ill 
and because of strong preferences of staff, service users 
and families.21 Therefore, we have designed a quasi-ex-
perimental cohort study of women accessing different 
types of acute psychiatric services within the first year 
after birth, comparing women’s outcomes to determine 
clinical effectiveness and cost-effectiveness of MBUs with 
generic acute wards and CRTs.
objECtIvEs
Our primary objective is to test the hypothesis that women 
with an acute psychiatric disorder, in the first year after 
giving birth, who are admitted to MBUs are significantly 
less likely to be readmitted to acute care (MBU, CRT or 
generic acute ward) in the year following discharge from 
acute care compared with those admitted to generic acute 
wards or under the care of CRTs.
We also hypothesise that admission to MBUs will be 
cost-effective compared with admission to generic wards or 
CRTs for the period between index admission to 1-month 
postdischarge, and for the period from discharge from 
index admission to 1-year postdischarge.
We are also testing the following secondary hypotheses:
Women with an acute psychiatric disorder, in the first 
year after giving birth, admitted to an MBU
a. Will have significantly fewer unmet health and social 
care needs 1-month postdischarge than those admitted 
to generic acute wards or under CRTs.
b. Will report significantly higher levels of service satis-
faction 1-month postdischarge than those admitted to 
generic acute wards or under CRTs.
c. Will have better maternal adjustment 1-month postdis-
charge than those admitted to generic acute wards or 
under CRTs.
d. Will be significantly more sensitive and less unrespon-
sive when interacting with their babies 1-month post-
discharge than those admitted to generic acute wards; 
similarly, their babies will be more cooperative and less 
passive.
e. Will be more likely to retain custody of their child than 
those admitted to generic acute wards or under CRTs 
in the year following discharge from acute care.
MEthods
Strengthening the Reporting of Observational Studies in 
Epidemiology reporting requirements for observational 
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research have been followed (see online supplementary 
material).
design
The study is a quasi-experimental cohort study embedded 
within existing service matrices.
service definitions
MBUs are defined here as units, with at least four beds 
and separate from other inpatient units, which provide 
specialised psychiatric care for both mother and baby 
where the mother has an acute perinatal psychiatric 
episode.21 22 Acute wards are defined as psychiatric wards 
that administratively record people receiving care as an 
inpatient admission, and which provide daily medical 
cover. CRTs are defined as intensive home treatment 
mental health teams that manage people in acute crises; 
the model of care includes rapid response, out of office 
hours multidisciplinary care.23 To ensure CRT treatment 
is available in study recruitment areas, CRTs have to be 
able to see people in mental health crises intensively 
(daily) where necessary; staff have to be available over an 
extended period (at least 12 hours a day) and the service 
has to have a specific crisis case load.
Patient involvement
A lived experience group set up at the time of earlier pilot 
work (RP-DG-1108–10012) contributed to the writing of 
the grant proposal and the study design; the primary and 
secondary outcomes of importance to them; assisted in 
ensuring that data collection tools were accessible and 
comprehensible; these tools were then piloted in 21 
women.
The lived experience group includes women (and their 
partners) recruited to represent the broadest possible 
spectrum of experience of perinatal mental health 
services. The group includes women who have experi-
enced treatment in psychiatric wards, CRTs, commu-
nity mental health services and MBUs. This group will 
continue to meet regularly throughout the duration of 
the study to advise on the execution and dissemination 
activities of the study.
study sample
Three cohorts of women with acute psychiatric disorders 
in the first year after childbirth, admitted to psychiatric 
MBUs, generic acute wards or CRTs are being recruited 
from mental healthcare provider organisations (Mental 
Health Trusts in England and Health Boards in Wales), 
selected to ensure diversity of urbanicity/rurality and 
access to MBUs. Women are eligible for the study if they 
used at least one acute service (MBUs, CRTs, generic 
acute wards), or any combination of all three, during the 
first year after childbirth.
Inclusion criteria
 ► Women with psychiatric disorders needing acute care 
in the first year after childbirth admitted to psychi-
atric MBUs, generic acute wards or CRTs.
 ► Women who have capacity to consent at the point of 
recruitment (at the point of or after discharge).
There are no diagnostic or language restrictions; we 
use an interpreter to conduct the research interview in 
instances where women meet the inclusion criteria but do 
not speak English.
Exclusion criteria
 ► Women using an acute service ‘prophylactically’ (ie, 
for close monitoring in high-risk cases or for statutory 
parenting assessments ie, not for acute psychiatric 
disorder).
 ► Women whose baby is permanently removed from 
their care prior to the admission.
 ► Women without capacity to consent at the point of 
recruitment.
In order to assess the representativeness of our study 
sample, we sought to obtain Section 251 approval to collect 
a minimum dataset— on readmissions, number of inpa-
tient and CRT days, Health of the Nation Outcome Scale, 
Mental Health Act status and age and ethnicity— from 
clinical records of all women admitted to each type of 
service for acute perinatal psychiatric disorders. Unfortu-
nately, our Section 251 application was not approved. It 
may, however, be possible for us to capture some of this 
data on the overall MBU population, from national audit 
data; we are not aware of any such audit data for the other 
acute care services.
recruitment method and study procedures
Our recruitment methods were successfully 
piloted in a National Institute for Health Research 
(NIHR) programme development grant (RP-DG-1108–
10012) and involve the following: study champions who 
are clinicians are identified for each ward, MBU and CRT. 
The study champion’s role is to be the named contact 
point for routine requests from researchers (every 
2–3 weeks) regarding any potentially eligible women 
admitted to their service. We are also enlisting recruit-
ment support from the regional NIHR Clinical Research 
Networks (CRNs), using Clinical Studies Officers that are 
based within trusts to help researchers liaise with acute 
services to identify eligible women. Engagement of clini-
cians is key to identifying eligible women and, alongside 
obtaining CRN support, we are adopting several other 
strategies to enhance engagement (see box 1: Engage-
ment activities at participating trusts below).
Postpartum women with capacity (assessed by trust 
clinical staff), when under acute care or shortly after 
discharge, are asked to agree or decline to be contacted by 
a researcher with information about the study. If women 
agree to be contacted, researchers establish contact with 
them at the point of, or soon after discharge. Researchers 
make a maximum of seven attempts to contact each 
eligible woman about the study (including calls, texts, 
emails and letters). Women are sent an appropriately 
worded and formatted participant information sheet and 
are given at least 24 hours to consider the information 
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before deciding whether to take part. If a woman agrees 
to participate, the researcher arranges a convenient and 
safe place to conduct a face-to-face research interview 
at around 1-month postdischarge. Written informed 
consent is obtained at the start of the interview, after 
establishing the woman has capacity to provide informed 
consent, including asking women to give optional addi-
tional consent for researchers to access their case notes 
to collect information regarding their index admission 
(ie, baseline data) and their outcomes in the year after 
discharge, and for a short 5 min telephone interview 
around 1-year postdischarge to collect follow-up informa-
tion on what has happened during the study.
Baseline data refers to the time period when women 
are under the care of acute services (ie, MBUs, CRTs and/
or generic acute wards) in the first year after childbirth. 
Baseline data are collected at the face-to-face research 
interview and retrospectively from clinical case notes, 
where women consent to this. Short-term outcome data 
refers to the time period from discharge from an MBU, 
CRT or generic acute ward to around 1-month postdis-
charge. Short-term outcome data are collected at the face-
to-face research interview. Long-term outcome data refers 
to the time period from discharge from an MBU, CRT or 
generic acute ward to 1-year postdischarge from services. 
Long-term outcome data are collected from health and 
social care case notes and via a brief telephone interview 
with women who have consented to the call. The reason 
for drawing on health and social care case note/file data 
is to reduce the potential burden on participants and 
reduce attrition. See table 1 for a full list of study assess-
ments and data collection time points.
The face-to-face research interview—conducted around 
a month after women have been discharged from acute 
services—takes up to 3 hours and includes assessment of 
outcomes for both women and their infants. Home visits 
are offered to women (where deemed safe and appro-
priate by clinical teams) so that women do not need to 
travel to interviews, and they can complete the interview 
over one or two sessions depending on their prefer-
ence. Women with older children who require childcare 
to take part are reimbursed for the costs of childcare. 
Interpreters are used for women who do not speak the 
same language as the researcher and who wish to take 
part. Women are offered up to £25 worth of vouchers as a 
thank you for taking part; women receive £15 of vouchers 
for completing assessments about themselves and an 
additional £10 for also completing the baby assessments.
During the face-to-face interview, participants are 
asked to nominate a significant other (eg, partner, family 
member and close friend) who supported them during 
their time under acute services. If a significant other is 
identified and consents, he/she is asked to complete a 
short 10–15 min questionnaire about his/her relationship 
with the participant, his/her experiences of caregiving 
for the participant and its impact, and items assessing 
current distress and mental health status. To facilitate 
data collection from significant others, the researchers 
offer significant others the chance to complete the ques-
tionnaires online or in paper format, with prepaid enve-
lopes provided. Successful returnees receive £10 shopping 
vouchers as a thank you for their contribution.
See image figure 1: Flow of participant diagram which 
illustrates the flow of participants through the study, 
based on the Consolidated Standards of Reporting Trials 
diagram24 and the Quality of Reporting of Observational 
Longitudinal Research guidelines.25
Measures
Table 1 outlines the measures used to collect data at all 
study time points, for women and their infants.
Process evaluation
As service provision varies nationally, we are collecting 
detailed descriptions of the service components of MBUs, 
CRTs and generic acute wards in participating provider 
organisations. We have developed a structured Process 
Evaluation questionnaire (available on request) guided 
by the research literature and via discussions between 
researchers and Programme Management Group 
members. The questionnaire is structured around three 
service component types: interventions, facilities and 
staff.
The ‘interventions’ component of the questionnaire 
comprises four distinct categories which examine the 
availability of specific types of interventions in the service: 
(1) psychological, (2) infant–parent relationship support, 
(3) support for partners/significant others and (4) 
social support. To chart exactly how these interventions 
are delivered, the questionnaire distinguishes between 
whether the services directly provide the intervention 
(ie, by staff within MBU/acute ward/CRT) or indirectly 
provide the intervention (ie, by other staff usually from 
external organisations, eg, health visitor). The question-
naire also charts the frequency in which interventions are 
delivered, defined as either: (1) ‘routinely provided’ (ie, 
a standard part of care received by many women) or (2) 
‘occasionally provided’ (ie, provided on an ad hoc basis).
The ‘facilities’ and ‘staff’ components of the question-
naire capture whether services have: (1) ‘full access’ to 
facilities and staff (ie, facilities are included within the 
box 1 Engagement activities at participating trusts
 ► Researchers set up meetings with trust staff to provide presenta-
tions on study progress.
 ► Researchers attend research-specific meetings to keep study 
champions and other trust staff engaged in the research.
 ► Researchers send out regular newsletter and social media updates 
on the study.
 ► Annual stakeholder workshops are held, providing updates on study 
progress and continuing professional development lectures from 
internationally renowned researchers and clinicians in the field of 
mental health (workshops are free for all study champions to attend).
 ► Continuing professional development workshops and/or lectures are 
offered by senior members of the research team.
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main service; staff are part of the core service team); 
(2) ‘partial access’ to facilities and staff (eg, psychologist 
providing CBT but not within the index unit) or (3) ‘no 
access’ to facilities and staff. The questionnaire has been 
piloted, and adjustments made where necessary.
Administration of the questionnaire is undertaken by a 
member of the research team, who schedules a telephone 
contact with a senior member of each service type and 
completes the questionnaire over the telephone. The ques-
tionnaire is emailed to the staff member ahead of the struc-
tured telephone interview, so they can review the forms and 
prepare answers in order to facilitate ease of completion.
Power calculation
Our pilot data using the Clinical Record Interactive Search 
(CRIS) database (the anonymised Case Register26 local to 
King’s College Hospital, London) revealed the following 
for 20 perinatal women on generic acute wards, 20 admitted 
to MBUs and 20 under CRTs: acute ward patients were most 
likely to be readmitted to these services with 95% being 
readmitted at some point during 12-month follow-up, 
compared with 35% of women who received MBU care; 
CRT readmission rates were similar to MBUs. Therefore, 
assuming similar readmission rates nationally for MBU 
patients (35%), we could detect a doubling of risk for 
generic acute ward patients with 90% power with 47 women 
in each group. We aim to recruit 100 women in each group; 
to allow for 20% attrition and exclusion of women for being 
beyond the ‘region of support’ (ie, whose characteristics 
make them unmatchable with women in another treatment 
arm—see Statistical methods section for further details).
Figure 1 Flow of participant diagram.
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AnAlysIs
statistical methods
There is limited availability of specialist MBU beds and 
it is, therefore, likely that some women who would be 
offered an MBU bed at first presentation are admitted to 
an acute ward, while waiting for a bed. As some women 
may also receive care from more than one type of inpa-
tient service (ie, MBU and acute ward) during their index 
admission, in our main analysis MBUs will be classified as 
the ‘highest level of care’ and we will run two sensitivity 
analyses—one based the majority of days spent within 
a specific inpatient service and the other based on first 
service accessed.
We shall use a propensity score approach to account 
for systematic differences between MBU and non-MBU 
participants. This approach allows the exact specifica-
tion of the covariate adjustment to be determined blind 
to the outcome data, thereby reducing the risk of unin-
tended bias. The Stata command p score will estimate the 
propensity score of the treatment (MBU or non-MBU) on 
specified covariates, selected using problem knowledge 
and exploratory comparison of cohorts, using a probit 
model and will stratify individuals in blocks according 
to the propensity score. The blocks are determined by a 
balancing algorithm and the balancing property within 
each block is tested, to ensure sufficient blocks are used 
to adequately balance the covariates. We will also remove 
women with characteristics that place them beyond the 
‘region of support’ and thus for whom there are no 
‘matches’, that is, women with propensity scores either so 
high or so low that there are insufficient similar women 
receiving either MBU or non-MBU treatment to make a 
comparison; we will report characteristics and outcomes 
for these women separately.
Once the propensity scores have been formed, they 
will be included in the primary and secondary analyses 
through use of the inverse propensity score weights27 (ie, 
weighted regressions will be performed), which will also 
be combined with the inverse probability weights for 
drop-out, known as attrition weights, specific to each 
endpoint measure. The readmission rate will be modelled 
using logistic regression, with adjustment for baseline 
measures that are likely to increase power, that is, base-
line measures of outcome and symptom severity. Point 
estimates, CI and significant tests based on the sandwich 
estimator of the parameter covariance matrix28 will be 
reported. Analysis on the primary outcome will include 
stratum specific treatment estimates. Trends in effect 
estimate over strata can be informative as to variability of 
effect, an advantage of using the stratification matching 
technique. The computation of average treatment effects 
will be restricted to the common region of support. Sensi-
tivity analyses will also be performed.
We shall also examine geographical and temporal varia-
tion in MBU services as a source of instrumental variables 
to account for unmeasured selection effects.
Missing data will be accounted for on three levels: single 
imputation or prorating for sporadic missing item-level 
data that contribute to scores, multiple imputation for 
entirely missing scales or factors and listwise deletion for 
those with insufficient data to allow plausible imputation.
Sensitivity analyses will examine the impact of different 
treatment arm definitions, formed following an examina-
tion of the observed treatment pathway patterns.
Economic evaluation
We will evaluate whether MBU services are cost-effec-
tive in the short term (from index admission to 1-month 
postdischarge) and the longer term (from discharge 
from the index admission to 1-year postdischarge) in the 
treatment of women with severe mental illness following 
birth, compared with generic acute wards and CRTs. 
Analysis from admission to 12 months was not considered 
appropriate because lengths of index admission may vary 
greatly, which would heavily influence the total cost and 
thus the results of the cost-effectiveness analysis.
The economic evaluation at 1-month postdischarge 
will take the NHS and personal social services perspec-
tive preferred by NICE,29 with data collected in face-to-
face interviews with participants using the Adult Service 
Use Schedule (AD-SUS) (see table 1 for full details of the 
AD-SUS measure). Since the index admission/acute care 
is the intervention, and since the development work indi-
cated that this can be difficult for women to recall, data on 
this will be taken from clinical notes. The AD-SUS, there-
fore, focuses primarily on hospital and community-based 
contacts postdischarge from the index admission.
The economic evaluation at 1-year postdischarge will 
take a narrower mental health perspective, with mental 
health service use data collected from clinical records 
and the EuroQol five-dimension scale (EQ-5D-5L) 
collected via brief telephone interviews, given no face-
to-face interviews with participants will take place at 
this time point. Resource use data for the period from 
the date of discharge from the index admission to the 
1-year postdischarge follow-up will be collated using a 
proforma created by the research team and collected 
from secondary mental health records. The proforma was 
piloted and edited as needed to ease data completion. 
This proforma will include all contacts with secondary 
mental health services including further periods in MBU, 
generic acute ward or CRT care plus any outpatient or 
community mental health contacts. A briefer version of 
the proforma will be used to collect data on the use of key 
acute services (MBUs, generic acute wards or CRTs) in 
the 2-year period prior to the index admission.
Resource use data will be combined with unit costs 
from national published sources to calculate the total cost 
of participants admitted to the MBU, CRT and generic 
acute wards for the two different time periods (from index 
admission to 1-month postdischarge and from discharge 
from the index admission to 1-year postdischarge).
Costs and outcomes will be compared and presented 
in terms of mean differences and 95% CIs obtained by 
non-parametric bootstrap regressions (10 000 repli-
cations) to account for the non-normal distribution 
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commonly found in economic data. Cost-effectiveness 
will be assessed through the calculation of incremental 
cost-effectiveness ratios30 and will be explored in terms 
of quality-adjusted life years (QALYs) calculated from 
the EQ-5D-5L31 and using the area under the curve 
approach.32 Utility data are not being collected at base-
line as women are not being interviewed until after 
discharge from the index admission. We will, therefore, 
use published utility values for a similar population 
(women in crisis (eg, Howard et al33)) as a substitute for 
utility at baseline. To provide more relevant treatment-ef-
fect estimates,34 all cost-effectiveness analyses will include 
prespecified covariates, in line with the main clinical anal-
ysis, plus the baseline variable of interest, where available. 
Uncertainty around the cost and effectiveness estimates 
will be represented by cost-effectiveness acceptability 
curves.35 The Short-Form Six-Dimension will be available 
at 1-month postdischarge and will be used to calculate 
QALYs to explore cost-effectiveness in the short term in 
a sensitivity analysis.36 Sensitivity analyses will also explore 
the impact of missing data.
EthICs
The study has obtained NHS Research Ethics Committee 
approval from the London-Camberwell St. Giles 
committee (number: 14/LO/0765). Research and devel-
opment (R&D) approval has been granted by all partici-
pating trusts and the three Welsh Health Boards, via the 
Wales Health and Care Research Permissions service. All 
researchers complete relevant training - for example, 
NIHR Good Clinical Practice in Secondary Care and 
the Health and Social Care Information Centre Informa-
tion Governance training; assessment of mental capacity; 
extraction of case note data —to ensure that they are 
appropriately skilled to undertake research with study 
participants.
Some participants will be very vulnerable, and our team 
will ensure close supervision of researchers to safeguard 
maternal and child welfare. Detailed guidance on safe-
guarding maternal and child welfare are outlined in the 
programme standard operating procedures,37 including 
instructions that researchers should follow if they iden-
tify any safeguarding concerns (ie, researchers will first 
contact one of the senior experienced clinical applicants 
on the programme grant to discuss their concerns and to 
identify what actions to undertake). Researchers under-
take regular clinical supervision with a senior clinician 
who is part of the research team.
Safety protocols have also been developed to ensure 
that participants, their families and researchers remain 
safe when making contact, conducting research and after-
wards. This includes the following precautions:
 ► On initial contact, researchers establish an appro-
priate contact number and time for future contact 
between themselves and participants.
 ► Researchers will ensure that the location(s) where an 
interview takes place is private and secure and cannot 
be overheard. The information provided by partici-
pants will be confidential and anonymised. In some 
situations, however, it may be necessary to disclose 
personal information without a patient’s consent if it is 
in the public interest (ie, where a failure to do so may 
expose the patient or others at risk of death or serious 
harm). The limits of confidentiality are explained on 
the participant information sheet and will be discussed 
with all participants as part of the informed consent 
process. The General Medical Council guidance on 
confidentiality will be followed.38 The researchers will 
contact one of the clinical applicants on the grant to 
discuss any situations when confidentiality may need 
to be broken.
 ► After the interview, researchers will ask participants 
how they feel and if they would like to discuss anything 
further with their responsible clinician.
 ► Researchers will give details of interview locations, 
start times and approximate end times to colleagues 
at their research department.
A study-specific protocol has been developed for the 
appropriate handling, management, storage and transfer 
of data. All data are stored in accordance with the Data 
Protection Act (2018) and General Data Protection Regu-
lations, with which all members of the research team are 
familiar.
dIssEMInAtIon
This study will provide evidence on effectiveness and 
cost-effectiveness (reducing readmission rates and 
improving quality of life), as well as identifying the 
services with which women themselves are most satis-
fied and those which produce the best outcomes for 
mothers (functioning, met needs), their infants (quality 
of mother–infant interaction) and significant others 
around them (carers’ needs). Throughout the study, we 
will produce regular newsletters and electronic updates 
for professionals and lay stakeholders. We will also hold 
yearly perinatal mental health workshops throughout 
the study to showcase the work to stakeholders and 
service users. We will present the study as poster and/or 
oral presentations at national and international confer-
ences; via social media (eg, Twitter) and press releases 
(eg, Maternal Mental Health Alliance); via articles for 
professionals, policy-makers and the public; via video 
talks and podcasts to relevant Royal Colleges, non-gov-
ernmental organisations and public groups. The main 
study findings will be published in an open access 
peer-reviewed journal, and we will highlight the work in 
relevant resource lists (eg, Public Health England Peri-
natal and Infant Mental Health eBulletin, Child and 
Maternal Health Knowledge Update of the National 
Child and Maternal Health Intelligence Network).
 o
n
 8 April 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-025906 on 23 March 2019. Downloaded from 
12 Trevillion K, et al. BMJ Open 2019;9:e025906. doi:10.1136/bmjopen-2018-025906
Open access 
study status
Recruitment of women admitted to services up to 
31 December 2017 was completed on 6 March 2018. Data 
collection of primary outcomes will continue until spring 
2019.
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